Journal List > Korean J Gastroenterol > v.80(2) > 1516079879

Adibi, Abdoli, Daghaghzadeh, Keshteli, Afshar, Roohafza, Esmaillzadeh, and Feizi: Relationship between Depression and Constipation: Results from a Large Cross-sectional Study in Adults

Abstract

Background/Aims

Accumulating evidence based on a few studies suggests a relationship between depression and functional constipation. This study examined whether depression is associated with a higher risk of functional constipation and whether it is gender specific.

Methods

This cross-sectional study was carried out on 3,362 adults aged 18-55 years. In this study, functional gastrointestinal symptoms were determined using an Iranian reliable and valid version of the modified Rome III questionnaire. The Iranian validated version of the hospital anxiety and depression scale was used to evaluate the psychological health. Scores of eight or more on the depression subscale in the questionnaire were considered the presence of depression. Simple and multiple binary logistic regression were used for data analysis.

Results

The mean±SD age of participants was 36.29±7.87 years, and 58.5% were female. The prevalence of depression and constipation in the study sample was 28.6% and 23.9%, respectively. In the full adjusted model, in the total sample, depressed people showed a significantly higher risk of constipation; adjusted OR (AOR), 1.69 (95% CI, 1.37-2.09). Although a significant association was observed between depression and constipation in both genders, the association was stronger in men than women (AOR, 2.28; 95% CI, 1.50, 3.63 vs. AOR, 1.55; 95% CI, 1.21, 1.99).

Conclusions

These study findings showed that depressed people are at a significantly higher risk of being affected by constipation. The current study findings justify the importance of mental health evaluations in all patients with functional gastrointestinal disorders, particularly among constipated individuals.

INTRODUCTION

Functional gastrointestinal disorders (FGIDs) are defined as a variable combination of chronic or recurrent gastrointestinal symptoms not explained by structural or biochemical abnormalities.1 Irritable bowel syndrome (IBS) and functional constipation (FC) are the most common functional gastrointestinal disorders. According to the Rome Ⅲ criteria, these disorders. In some populations, it is the most common digestive complaint, which leads to a large number of medical visits.4 In a previous cohort study in 2018, Moezi et al.5 evaluated the prevalence of CC and its associated factors. Among 9,000 adults in southern Iran, 752 participants (8.1%) were diagnosed with CC (9.3% and 6.7% of the female and male participants, respectively).5 Previous studies reported a wide range of prevalences CC (2-27% with an average of 15% in most studies).6 This wide range is due to different study populations and different inclusion criteria, e.g., studies that reported the prevalence based upon self-reporting showed higher prevalence than those that used the ROME criteria,7 or studies conducted in Southeast Asia reported lower prevalence compared to American and European studies.8-10
Several factors are associated with constipation. Based on previous studies, some risk factors for functional constipation include female sex, older age, low socioeconomic status, physical inactivity, and insufficient fluid and fiber consumption.10-12 In addition, a set of psychological variables can be related to constipation. Cheng et al.13 investigated the prevalence of functional constipation in an Asian population and the interplay among functional constipation, anxiety/depression, perception, and coping strategies. Albiani et al.14 examined anxiety and depression as potential mediators of the relationship between constipation severity and quality of life in a sample of 142 constipated patients. Fond et al.15 evaluated the associations of IBS and its subtypes with anxiety or depression. Ballou et al.16 investigated the relationship between depression and bowel habits, controlling for the clinical and demographic factors, in a representative sample of the United States population in the framework of the National Health and Nutrition Examination Survey. Mokhtar et al.17 evaluated the prevalence of depression among patients with constipation- predominant IBS (IBS-C).
Overall, accumulating evidence based on a few studies suggests a relationship between depression and functional constipation. On the other hand, more studies are needed to provide more reliable evidence. Therefore, this study examined whether depression is associated with a higher risk of functional constipation and whether this relationship is gender specific.

SUBJECTS AND METHODS

1. Study design and subjects

The present study was a cross-sectional study in the framework of the SEPAHAN project. The SEPAHAN study examined the epidemiological aspects of functional gastrointestinal disorders and their relationship with lifestyle and psychiatric factors on 10,500 non-academic staff apart from the treatment department of Isfahan University of Medical Sciences and Health Services in April 2010. The sample consisted of non-academic staff working in 50 centers across Isfahan province, Iran. The staff were directly involved in health services, working in hospitals, university campuses, and health centers. In the SEPAHAN study, the questionnaires were distributed in two stages with a short time interval (3 to 4 weeks) to increase the rate of response and participation of individuals and the accuracy of the collected data. In the first stage, a demographic information questionnaire, nutritional performance, health search behaviors, and food intake, and in the second set of questionnaires. The participants were asked about information about gastrointestinal and mental and physical illnesses, personality traits, perceived stresses, and coping styles. The response rate in the first stage was 86.1% and in the second stage was 64.64%. After merging the data in these two stages, complete information was obtained from 4,763 people. In the current secondary study, 3,362 with complete data on all variables were included. More complete information on the SEPAHAN project can be found in other published articles.18

2. Depression assessment

The hospital anxiety and depression scale (HADS) was used to evaluate depression. The HADS contains 14 items and consists of two subscales of anxiety and depression. Each item is rated on a four-point scale, with the anxiety and depression subscales separately obtaining a maximum score of 21. Scores of eight or more on either subscale are considered a significant case of psychological morbidity, and 0-7 were normal.19 The validated Persian version of HADS with Cronbach alpha of 0.86 for depression subscale was used.20

3. Constipation assessment

Functional gastrointestinal symptoms were determined using an Iranian reliable and valid modified version of Rome III questionnaire, 21 which diagnoses functional gastrointestinal disorders and consists of six major domains, with functional oesophageal disorders and functional gastrointestinal disorders being two domains in the questionnaire for adults. Each domain contains several questions to aid in diagnosing these disorders based on Rome III criteria. According to the Rome III criteria, constipation was defined as the presence of at least one or two of the following symptoms, for at least 3 months, with the onset at least 6 months preceding this study.
1) Straining during in at least 25% of defecations (at least often).
2) Lumpy or hard stools in at least 25% of defecations (at least often).
3) Sensation of incomplete evacuation in at least 25% of defecations (at least sometimes).
4) Sensation of anorectal obstruction/blockage in at least 25% of defecations (at least sometimes).
5) Manual maneuvers facilitate at least 25% of defecations (e.g., digital evacuation, support of the pelvic floor) (at least sometimes).
6) Fewer than three defecations per week.

4. Other variables

Self-administered questionnaires were used to collect information regarding age (years), sex (male, female), marital status (married, single), education level (under diploma, diploma (12-years formal education), collegiate), and anthropometric measures, including weight, height, and body mass index (BMI=weight [kg]/height square [m2]). Smoking and physical activity based on self-reported questions were also evaluated. The participants were divided into three categories “nonsmoker”, “ex-smoker”, or “current smoker”. The general practice physical activity questionnaire was used to evaluate physical activity levels.22 The level of physical activity in the current study was considered to be less than 1 hour/week/more than 1 hour/week. Usual dietary intakes during the preceding 12 months were assessed using a validated 106-item self-administered semi-quantitative dish-based food frequency questionnaire (FFQ) designed especially for adults living in Isfahan province.23 The semi-quantitative FFQ included 36 questions to assess the intake of most commonly consumed fruits and vegetables (raw or cooked as mixed dishes). Those fruits and vegetables that are consumed raw include cucumbers, tomatoes, dates, raisins, herbs, dried berries, salad, citrus, apples or pears, cherries, apricot, plum, raw onions, kiwi, strawberries, grapes, pomegranate, mulberry, banana, figs, and all kinds of fruit juice. Daily intakes of nutrients (g/day), including individual dietary fiber, were calculated for each participant using the US department of agriculturés nutrient databank.24 Fluid intake was evaluated through questions on the consumption of water, soft drinks, yogurt drink (“dough”), and other beverages, before, after, or during meals, which the participants could answer as never, sometimes, often, or always.25 Data on the current use of psychotropic medications (including nortriptyline, amitriptyline or imipramine, fluoxetine, citalopram, fluvoxamine, and sertraline) as (yes/no) were gathered using a self-reported questionnaire and a history of any predisposing chronic diseases (non-disease/disease), including diabetes mellitus and cardiovascular diseases, was also collected from the participants.

5. Statistical analysis

The continuous and categorical basic characteristics of the study subjects are presented as the mean (SD) and frequency of chronic diseases (percentage), and compared between study groups using independent samples t-test and chi-squared test, respectively. Binary logistic regression analysis was used to find the association between depression and constipation. The ORs were reported with the corresponding 95% CIs. Multiple binary logistic regression was used to estimate the adjusted ORs (95% CI) in association analyses between depression and constipation.
Separate models were used to fit the association between constipation and depression. In simple binary logistic regression analysis, this study only evaluated the crude association between depression and constipation. Multivariable analyses were performed in the first model, adjusting for age, sex, marital status, and education level. Further adjustment was made for smoking habits, physical activity, fluid consumption, fruits, vegetables, and total dietary fiber intakes. In the final model, further adjustment was made for chronic disease and psychotropic medication use. All statistical analyses were conducted using Statistical Package for Social Sciences (SPSS, Inc., Chicago IL, United States; version 16). p<0.05 was considered significant in all statistical analyses.

RESULTS

The mean±standard deviation age of the 3,674 study subjects was 36.29±7.87 years, and 58.5% were female. Table 1 lists the general characteristics of the study population stratified according to the status of functional constipation. The prevalence of FC in this study was 23.9% (15% in men and 30.2% in women). The prevalence of functional constipation was higher in women (p<0.001) and less physically active people (p<0.05). The weight and fluid consumption were significantly lower in constipated people (p<0.001 for both). In contrast, those who consumed psychotropic medicines (p<0.001) and depressed people were affected more significantly by constipation (p<0.001) (Table 1).
Table 2 lists the general characteristics of the study population stratified according to the status of depression. The prevalence of depression in this study was 28.6% (20.8% in men and 34.1% in women). The prevalence of depression was significantly higher in women (p<0.001), less educated (p<0.001), current smokers (marginally, p=0.063), constipated people (p<0.001), less activated (p<0.001), and people with chronic diseases (p<0.001). The mean weight (p<0.001) and mean intake of dietary fiber (p=0.001), fruits (p=0.006), and vegetables (p<0.001), were significantly lower in depressed people than in non-depressed people (Table 2).
The crude and multivariable-adjusted OR (95% CI) of constipation across the categories of depression are illustrated in Table 3. In the crude model, in the total sample, depressed people showed a higher significant risk of constipation OR, 1.97 (95% CI, 1.66-2.33). The risk of constipation in depressed people was 1.97 times that of non-depressed people. Although observed a significant association was observed between depression and constipation in both genders, the association was stronger in men than women (OR, 2.64; 95% CI, 1.91, 3.64 vs. OR, 1.52; 95% CI, 1.24, 1.86). In men, the risk of constipation in depressed people was 2.64 times that of non-depressed people, and in women, the risk of constipation in depressed people was 1.52 times that of non-depressed people.
In the full adjusted model in the total sample, depressed people showed a significantly higher risk of constipation (AOR, 1.69; 95% CI, 1.37-2.09). The risk of constipation in depressed people was 1.69 times that of non-depressed people. Although a significant association was observed between depression and constipation in both genders, the association was stronger in men than women (AOR, 2.28; 95% CI, 1.50, 3.63 vs. AOR, 1.55; 95% CI, 1.21, 1.99). In men, the risk of constipation in depressed people was 2.28 times that of non-depressed people, while in women, the risk of constipation in depressed people was 1.55 times that of non-depressed people.

DISCUSSION

In the current secondary analysis of a large cross-sectional study of general adults, depression was significantly associated with an increased risk of constipation. This is the first study to evaluate the relationship between depression and constipation in a large representative adult sample in Iran.
The prevalence of FC in this study was 23.9% (15% in men and 30.2% in women), which was higher than the reported prevalence in a recently published systematic review and meta-analysis. The estimated global prevalence of FC based on ROME III was 10.4% (6.5-14.9).26 On the other hand, in previous studies in western countries, the estimated FC prevalence was less than that reported in the present study. According to a systematic review in North America, the prevalence ranged from 1.9% to 27%, with an average of 15% in most studies.6 According to another meta-analysis, the pooled prevalence in South America was 18%, and 16% in northern and southern Europe, while they were 14% and 11% in the middle eastern and southeast Asian studies, respectively.10 In a study conducted in Tehran province, 2.4% of the general population were diagnosed with FC based on the Rome III criteria.27 Another study conducted in Isfahan showed that 9.6% of the participants had constipation, according to self-reports.28 Another study conducted in Kerman, showed a prevalence of 9.4%.29
The estimated FC prevalence in the present study, unlike other studies conducted in Iran, was higher than in western countries. This was attributed to different lifestyles in the Iranian population.27,30 Currently, the intake of fibers (vegetables and fruit) has decreased in the Iranian diet, while the consumption of bread and rice has increased.31 The second reason for this higher prevalence may be the style of the Iranian toilet. On normal defecation, relaxation of the puborectalis and external anal sphincter with increased intra-abdominal pressure straightens the anorectal angle and leads to defecation. Because of less hip flexion in an Iranian toilet, the anorectal angle is narrower than in a European toilet. This wide-angle helps complete evacuation.32
In this study, 33.3% and 20.2% of depressed and non-depressed people, respectively, had constipation. These findings are consistent with previous studies that found depression to be associated with constipation. For example, Moezi et al.5 revealed a significant association between depression and constipation. Ballou et al.16 reported a significant association between depression and constipation.
In previous studies, the relationship between mood and gastrointestinal disorders is unique from other chronic illnesses because of the significant interplay between the central nervous system and the gastrointestinal tract, also known as the brain-gut axis. For example, studies of neuronal stress pathways found that the corticotropin-releasing factor (CRF) in the brain plays a significant role in mediating the relationship between emotional distress and changes in the upper and lower gastrointestinal (GI) motor function.33,34 In functional GI disorders, such as IBS, functional dyspepsia, and CC or diarrhea, dysfunction of the autonomic nervous system, which acts directly on CRF, may play a role in changing the bowel habits and gastric emptying.35 Similarly, depression is associated with hyperactivity of the CRF neuronal pathways,36 and CRF receptors have been suggested as a possible treatment target for depression and GI disorders37,38 consistent activation of the stress pathways mentioned above may lead to dysfunction in the brain-gut axis, making depressed patients more susceptible to symptoms, such as chronic diarrhea or chronic constipation.16
In particular, psychiatric disorders, such as depression, may be associated with constipation due to the effect of the disease itself or to other associated factors. Patients with depression and other psychiatric disorders generally have unhealthy lifestyles, such as poor diet, poor fluid intake,39 and inactivity, as observed in the present study population. This may contribute to the occurrence of constipation.40
These findings on the depression among constipation patients are an excellent start to alerting medical practitioners in this country regarding the importance of having to refer patients to the appropriate physicians. Nevertheless, this study has several limitations. The most important among them is that no causal inferences can be drawn because of the cross-sectional design. The other limitation of this study was that information was unavailable regarding previous medical utilization by patients. While everyone in this study received an initial medical consultation to determine the constipation severity, there is no information regarding which previous medical treatment is most suitable. Depressed people are at a significantly higher risk of constipation. These study findings justify mental health evaluations in all patients with functional gastrointestinal disorders, particularly among constipated individuals.

ACKNOWLEDGEMENTS

We express our many thanks to all people who consented and participated in SEPAHAN study.

Notes

Financial support

None.

Conflict of interest

None.

REFERENCES

1. Rasquin A, Di Lorenzo C, Forbes D, et al. 2006; Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 130:1527–1537. DOI: 10.1053/j.gastro.2005.08.063. PMID: 16678566. PMCID: PMC7104693.
2. Bellini M, Gambaccini D, Usai-Satta P, et al. 2015; Irritable bowel syndrome and chronic constipation: fact and fiction. World J Gastroenterol. 21:11362–11370. DOI: 10.3748/wjg.v21.i40.11362. PMID: 26523103. PMCID: PMC4616212.
3. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. 2006; Functional bowel disorders. Gastroenterology. 130:1480–1491. DOI: 10.1053/j.gastro.2005.11.061. PMID: 16678561.
4. Choung RS, Branda ME, Chitkara D, et al. 2011; Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther. 33:251–260. DOI: 10.1111/j.1365-2036.2010.04513.x. PMID: 21091523. PMCID: PMC3242366.
5. Moezi P, Salehi A, Molavi H, et al. 2018; Prevalence of chronic constipation and its associated factors in pars cohort study: a study of 9000 adults in Southern Iran. Middle East J Dig Dis. 10:75–83. DOI: 10.15171/mejdd.2018.94. PMID: 30013755. PMCID: PMC6040930.
6. Higgins PD, Johanson JF. 2004; Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 99:750–759. DOI: 10.1111/j.1572-0241.2004.04114.x. PMID: 15089911.
7. Jun DW, Park HY, Lee OY, et al. 2006; A population-based study on bowel habits in a Korean community: prevalence of functional constipation and self-reported constipation. Dig Dis Sci. 51:1471–1477. DOI: 10.1007/s10620-006-9087-3. PMID: 16832618.
8. Sorouri M, Pourhoseingholi MA, Vahedi M, et al. 2010; Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol. 16:154–160. DOI: 10.4103/1319-3767.65183. PMID: 20616409. PMCID: PMC3003223.
9. Basaranoglu M, Celebi S, Ataseven H, Rahman S, Deveci SE, Acik Y. 2008; Prevalence and consultation behavior of self-reported rectal bleeding by face-to-face interview in an Asian community. Digestion. 77:10–15. DOI: 10.1159/000114827. PMID: 18230973.
10. Suares NC, Ford AC. 2011; Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 106:1582–1592. DOI: 10.1038/ajg.2011.164. PMID: 21606976.
11. Chu H, Zhong L, Li H, Zhang X, Zhang J, Hou X. 2014; Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in china. Gastroenterol Res Pract. 2014:532734. DOI: 10.1155/2014/532734. PMID: 25386187. PMCID: PMC4216714.
12. Choung RS, Locke GR 3rd, Rey E, et al. 2012; Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol. 10:494–500. DOI: 10.1016/j.cgh.2011.12.041. PMID: 22289877. PMCID: PMC3589972.
13. Cheng C, Chan AO, Hui WM, Lam SK. 2003; Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study. Aliment Pharmacol Ther. 18:319–326. DOI: 10.1046/j.1365-2036.2003.01663.x. PMID: 12895216.
14. Albiani JJ, Hart SL, Katz L, et al. 2013; Impact of depression and anxiety on the quality of life of constipated patients. J Clin Psychol Med Settings. 20:123–132. DOI: 10.1007/s10880-012-9306-3. PMID: 22581107.
15. Fond G, Loundou A, Hamdani N, et al. 2014; Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 264:651–660. DOI: 10.1007/s00406-014-0502-z. PMID: 24705634.
16. Ballou S, Katon J, Singh P, et al. 2019; Chronic diarrhea and constipation are more common in depressed individuals. Clin Gastroenterol Hepatol. 17:2696–2703. DOI: 10.1016/j.cgh.2019.03.046. PMID: 30954714. PMCID: PMC6776710.
17. Mokhtar NM, Bahrudin MF, Abd Ghani N, Abdul Rani R, Raja Ali RA. 2020; Prevalence of subthreshold depression among constipation-predominant irritable bowel syndrome patients. Front Psychol. 11:1936. DOI: 10.3389/fpsyg.2020.01936. PMID: 32849137. PMCID: PMC7423989.
18. Adibi P, Keshteli AH, Esmaillzadeh A, et al. 2012; The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): overview of methodology. J Res Med Sci. 17:S292–S298.
19. Bjelland I, Dahl AA, Haug TT, Neckelmann D. 2002; The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 52:69–77. DOI: 10.1016/S0022-3999(01)00296-3. PMID: 11832252.
20. Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. 2003; The hospital anxiety and depression scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes. 1:14. DOI: 10.1186/1477-7525-1-14. PMID: 12816545. PMCID: PMC161819.
21. Toghiani A, Maleki I, Afshar H, Kazemian A. 2016; Translation and validation of the Farsi version of Rome III diagnostic questionnaire for the adult functional gastrointestinal disorders. J Res Med Sci. 21:103. DOI: 10.4103/1735-1995.193175. PMID: 28250780. PMCID: PMC5322693.
22. General practice physical activity questionnaire (GPPAQ). [Internet]. CITY: GOV.UK;2013. cited 2021 Oct 20. Available from: https://www.gov.uk/government/publications/generalpractice-physical-activity-questionnaire-gppaq.
23. Keshteli A, Esmaillzadeh A, Rajaie S, Askari G, Feinle-Bisset C, Adibi P. 2014; A dish-based semi-quantitative food frequency questionnaire for assessment of dietary intakes in epidemiologic studies in Iran: design and development. Int J Prev Med. 5:29–36. PMID: 24554989. PMCID: PMC3915470.
24. USDA national nutrient database for standard reference, legacy release. [Internet]. Washington (DC): US Department of Agriculture;2019. cited 2021 Oct 20. Available from: https://data.nal.usda.gov/dataset/usda-national-nutrient-database-standard-reference-legacy-release.
25. Esmaillzadeh A, Keshteli AH, Hajishafiee M, Feizi A, Feinle-Bisset C, Adibi P. 2013; Consumption of spicy foods and the prevalence of irritable bowel syndrome. World J Gastroenterol. 19:6465–6471. DOI: 10.3748/wjg.v19.i38.6465. PMID: 24151366. PMCID: PMC3801318.
26. Barberio B, Judge C, Savarino EV, Ford AC. 2021; Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 6:638–648. DOI: 10.1016/S2468-1253(21)00111-4. PMID: 34090581.
27. Kaboli SA, Pourhoseingholi MA, Moghimi-Dehkordi B, Safaee A, Habibi M, Pourhoseingholi A, Vahedi M. 2010; Factors associated with functional constipation in Iranian adults: a population-based study. Gastroenterology and Hepatology From Bed to Bench. 3:83–90.
28. Adibi P, Behzad E, Pirzadeh S, Mohseni M. 2007; Bowel habit reference values and abnormalities in young Iranian healthy adults. Dig Dis Sci. 52:1810–1813. DOI: 10.1007/s10620-006-9509-2. PMID: 17410463.
29. Zahedi MJ, Moghadam SD, Abbasi MH, Mirzaei SM. 2014; The assessment prevalence of functional constipation and associated factors in adults: a community-based study From Kerman, Southeast, Iran (2011-2012). Govaresh. 19:95–101.
30. Patimah AW, Lee YY, Dariah MY. 2017; Frequency patterns of core constipation symptoms among the Asian adults: a systematic review. BMC Gastroenterol. 17:115. DOI: 10.1186/s12876-017-0672-z. PMID: 29096625. PMCID: PMC5667456.
31. Davudi Kh, Volkova LIu. 2007; Structure of nutrition in Iranian population. Vopr Pitan. 76:56–61. PMID: 17674522.
32. Rad S. 2002; Impact of ethnic habits on defecographic measurements. Arch Iran Med. 5:115–117.
33. Mönnikes H, Tebbe JJ, Hildebrandt M, et al. 2001; Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis. 19:201–211. DOI: 10.1159/000050681. PMID: 11752838.
34. Taché Y, Martinez V, Million M, Wang L. 2001; Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol. 280:G173–G177. DOI: 10.1152/ajpgi.2001.280.2.G173. PMID: 11208537.
35. Mayer EA, Naliboff BD, Chang L, Coutinho SV. 2001; V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 280:G519–G524. DOI: 10.1152/ajpgi.2001.280.4.G519. PMID: 11254476.
36. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. 1999; The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol. 160:1–12. DOI: 10.1677/joe.0.1600001. PMID: 9854171.
37. Kehne JH. 2007; The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders. CNS Neurol Disord Drug Targets. 6:163–182. DOI: 10.2174/187152707780619344. PMID: 17511614.
38. Taché Y, Kiank C, Stengel A. 2009; A role for corticotropin-releasing factor in functional gastrointestinal disorders. Curr Gastroenterol Rep. 11:270–277. DOI: 10.1007/s11894-009-0040-4. PMID: 19615302. PMCID: PMC3295847.
39. Osborn DP, Nazareth I, King MB. 2007; Physical activity, dietary habits and Coronary Heart Disease risk factor knowledge amongst people with severe mental illness: a cross sectional comparative study in primary care. Soc Psychiatry Psychiatr Epidemiol. 42:787–793. DOI: 10.1007/s00127-007-0247-3. PMID: 17721669.
40. Lindberg G, Hamid SS, Malfertheiner P, et al. 2011; World Gastroenterology Organisation global guideline: constipation--a global perspective. J Clin Gastroenterol. 45:483–487. DOI: 10.1097/MCG.0b013e31820fb914. PMID: 21666546.

Table 1
General Characteristics of Participants Based on Categories of Functional Constipation
Variable Functional constipation p-value

No (n=2,560) Yes (n=802)
Age (years) 36.25±7.94 36.42±7.63 0.623a
Sex <0.001b
Male 1,193 (85) 210 (15)
Female 1,367 (69.8) 592 (30.2)
Education level 0.583b
Under diploma 982 (76.7) 299 (23.3)
Collegiate 1,578 (75.8) 503 (24.2)
Marital Status 0.418b
Married 2,042 (75.9) 648 (24.1)
Single 430 (78.5) 118 (21.5)
Divorced or widowed 41 (74.5) 14 (25.5)
Smoking habits 0.424b
Non smoker 2,209 (76.2) 689 (23.8)
Current smoker 75 (79.8) 19 (20.2)
Physical activity 0.016b
Less than 1 hour/week 1,547 (74.6) 526 (25.4)
More than 1 hour /week 823 (78.5) 225 (21.5)
Weight (kg) 69.24±13.55 66.76±11.75 <0.001a
BMI (kg/m2) 24.89±3.83 24.96±3.81 0.632a
Total dietary fiber (g/day) 22.67±9.69 21.99±9.36 0.082a
Fruits (g/day) 319.43±245.24 304.76±234.21 0.135a
Vegetables (g/day) 238.34±131.22 235.70±130.93 0.619a
Fluid consumption (L/day) 1.35±0.58 1.26±0.51 <0.001a
Psychotropic medicines <0.001b
No 2,441 (76.9) 734 (23.1)
Yes 119 (63.6) 68 (36.4)
Chronic diseases 0.592b
Non disease 2,444 (76.2) 762 (23.8)
Disease 116 (74.4) 40 (25.6)
Depression <0.001b
No 1,878 (79.8) 476 (20.2)
Yes 629 (66.7) 314 (33.3)

Values are presented as number (%) or mean±standard deviation. p<0.05 is considered as significant.

BMI, body mass index.

at-test; bChi-squared test.

Table 2
General Characteristics of Participants Based on the Categories of Depression
Variable Depression p-value

No Yes
Age (years) 36.13±7.94 36.32±7.61 0.562a
Sex <0.001b
Male 10.82 (79.2) 285 (20.8)
Female 1,272 (65.9) 658 (34.1)
Education level <0.001b
Under graduate and diploma 837 (66.9) 414 (33.1)
University graduate 1,517 (74.1) 529(25.9)
Marital Status 0.001b
Married 1,901 (72.2) 733 (27.8)
Single 380 (70.0) 163 (30.0)
Divorced or widowed 26 (49.1) 27 (50.9)
Smoking habits 0.063b
Non smoker 2,064 (72.6) 779 (27.4)
Current smoker 58 (63.7) 33 (36.3)
Physical activity <0.001b
Less than 1 hour/week 1,394 (63.6) 2,034 (66.4)
More than 1 hour/week 797 (36.4) 1,027 (33.6)
Weight (kg) 69.12±13.19 67.16±12.99 <0.001a
BMI (kg/m2) 24.91±3.70 24.85±4.10 0.712a
Total dietary fiber (g/day) 22.83±9.60 21.65±9.64 0.001a
Fruits (g/day) 330.54±247.86 276.67±218.09 <0.001a
Vegetables (g/day) 241.78±129.20 227.71±137.19 0.006a
Fluid consumption (L/day) 1.32±0.56 1.34±0.58 0.548a
Psychotropic medicines <0.001b
No 2,278 (72.2) 837 (27.8)
Yes 76 (41.8) 106 (58.2)
Chronic diseases <0.001b
Non disease 2,272 (96.5) 3,146 (95.4)
Disease 52 (3.5) 151 (45.7)
Constipation <0.001b
No 1,878 (74.9) 2,507 (25.1)
Yes 476 (61.3) 790 (39.7)

Values are presented as number (%) or mean±standard deviation. p<0.05 is considered as significant.

BMI, body mass index.

at-test; bChi-squared test.

Table 3
Relationship between Depression and Constipation by the Logistic Regression Model
Total (OR [95% CI]) Men (OR [95% CI]) Women (OR [95% CI])
Crude 1.97 (1.66, 2.33) 2.64 (1.91, 3.64) 1.52 (1.24, 1.86)
Model 1a 1.83 (1.52, 2.21) 2.78 (1.94, 3.99) 1.59 (1.28, 1.97)
Model 2b 1.76 (1.43, 2.17) 2.31 (1.54, 3.46) 1.62 (1.27, 2.07)
Model 3c 1.69 (1.37, 2.09) 2.28 (1.50, 3.63) 1.55 (1.21, 1.99)

OR, odds ratio; CI, confidence interval.

aAdjusted for age, sex, marital status and education level only in the whole population; bFurther adjustment was made for smoking habits, physical activity, fluid consumption, fruits, vegetables, and total dietary fiber; cFurther adjustment was made for chronic disease, psychotropic medicines.

TOOLS
Similar articles